Light and ultrasound drive lignin chemistry to two drug-research compounds in lab tests

Selectivity and yield answer different questions, and the two studies report them at opposite ends. Selectivity is the share of converted starting material that becomes the target. Yield is the share of all starting material that does. The diapocynin route reached more than 97% selectivity with a 33% yield ^[7]. On the usual definitions of those terms, no more than about 34% of the acetovanillone can have reacted ^[12]. The coniferyl alcohol route is the mirror image: every molecule of substrate was converted, but selectivity to DHCA was 54% ^[3], so about 46% of what reacted became something else ^[13].

Phys.org's account says yield, molecular scope and scale-up still require further work ^[9].

Scale-up is where the sound field will matter. As the source describes it, cavitation delivers energy locally, where the chemistry happens, without taking the whole system to extreme heat ^[2]. We'd expect the distribution of that energy to change with vessel geometry, so a larger reactor would have to reproduce the field and not only the power.

The renewable claim is firmest for the diapocynin catalyst, which is built from lignin and chitosan ^[6]. Lignin is a major byproduct of wood processing, and its aromatic structures can be used as building blocks for more valuable compounds ^[10]. The compounds themselves are early-stage research targets. Diapocynin is the dimer of the NADPH oxidase inhibitor apocynin and is being investigated in disease models for limiting damaging reactive oxygen species ^[8].

The summary gives no baseline. It reports no run without ultrasound or light, no conventional route for comparison, no origin for the acetovanillone and no statement on whether either reaction used an oxidant. Both studies came from IPC PAS Research Group 28, led by Juan Carlos Colmenares, and are described as laboratory proofs of concept ^[1].